Inhibitory Effect of a Hot-Water Extract of Leaves of Japanese Big-Leaf Magnolia (Magnolia obovata) on Rotavirus-Induced Diarrhea in Mouse Pups

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Kawahara, Takeshi ^a   Tomono, Takuma ^a   Hamauzu, Yasunori ^a   Tanaka, Katsumi ^b   Yasui, Hisako ^b  

^a SHINSHU UNIVERSITY   (Japan)

^b Kiso Town Resources Institute   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HOT WATER; MAGNOLIA OBOVATA EXTRACT; MESSENGER RNA; PLANT EXTRACT; PROTEIN INHIBITOR; QUERCITRIN; ROTAVIRUS VACCINE; RUTOSIDE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ACUTE DIARRHEA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DRUG EFFECT; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; GENE AMPLIFICATION; IC50; JAPAN; MAGNOLIA; MAGNOLIA OBOVATA; MOUSE; NEWBORN; NONHUMAN; PACKAGING MATERIAL; PLANT LEAF; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; RHESUS MONKEY; ROTAVIRUS; ROTAVIRUS INDUCED DIARRHEA; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; VIRUS REPLICATION;

EID: 84938349096     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/365831     Document Type: Article

References (30)

1. M. Mori, M. Aoyama, and S. Doi, "Antifungal constituents inthe bark ofMagnolia obovata Thunb, " Holz als Roh-undWerkstoff, vol. 55, no. 4, pp. 275-278, 1997.
2. Y.-J. Lee, Y. M. Lee, C.-K. Lee, J. K. Jung, S. B. Han, and J. T. Hong, "Therapeutic applications of compounds in the Magnolia family, " Pharmacology & Therapeutics, vol. 130, no. 2, pp. 157-176, 2011.
3. K. Tomonaga and K. Ikuta, "Establishment of a reverse genetics system for rotavirus: A multisegmented, double-stranded RNA virus, " Future Virology, vol. 1, no. 5, pp. 573-576, 2006.
4. U. D. Parashar, C. J. Gibson, J. S. Bresee, and R. I. Glass, "Rotavirus and severe childhood diarrhea, " Emerging Infectious Diseases, vol. 12, no. 2, pp. 304-306, 2006.
5. P. H. Dennehy, "Transmission of rotavirus and other enteric pathogens in the home, "ThePediatric InfectiousDisease Journal, vol. 19, no. 10, pp. S103-S105, 2000.
6. N. Lloyd-Evans, V. S. Springthorpe, and S. A. Sattar, "Chemical disinfection of human rotavirus-contaminated inanimate surfaces, " Journal of Hygiene, vol. 97, no. 1, pp. 163-173, 1986.
7. D. I. Bernstein, "Live attenuated human rotavirus vaccine, Rotarix, " Seminars in Pediatric Infectious Diseases, vol. 17, no. 4, pp. 188-194, 2006.
8. D. O. Matson, "The pentavalent rotavirus vaccine, RotaTeq, " Seminars in Pediatric Infectious Diseases, vol. 17, no. 4, pp. 195-199, 2006.
9. L. B. Madsen, M. Ustrup, T. K. Fischer, I. C. Bygbjerg, and F. Konradsen, "Reduced price on rotavirus vaccines: enough to facilitate access where most needed" Bulletin of the World Health Organization, vol. 90, no. 7, pp. 554-556, 2012.
10. J. L. S. Gonçalves, R. C. Lopes, D. B. Oliveira et al., "In vitro anti-rotavirus activity of some medicinal plants used in Brazil against diarrhea, " Journal of Ethnopharmacology, vol. 99, no. 3, pp. 403-407, 2005.
11. R. T. Majinda, S. O. Yeboah, J. C. Jackson, P. T. Kapewangolo, M. Kandawa-Schulz, and A. Cencic, "Tylosema esculentum (Marama) tuber and bean extracts are strong antiviral agents against rotavirus infection, " Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 284795, 11 pages, 2011.
12. K. Knipping, J. Garssen, and B. van't Land, "An evaluation of the inhibitory effects against rotavirus infection of edible plant extracts, " Virology Journal, vol. 9, article no. 137, 2012.
13. Y. Kadooka, K. Tominari, F. Sakai, and H. Yasui, "Prevention of rotavirus-induced diarrhea by preferential secretion of IgA in breast milk via maternal administration of Lactobacillus gasseri SBT2055, " Journal of Pediatric Gastroenterology and Nutrition, vol. 55, no. 1, pp. 66-71, 2012.
14. M. Arnold, J. T. Patton, and S. M. McDonald, "Culturing, storage, and quantification of rotaviruses, " in Current Protocols in Microbiology, chapter 15, unit 15C3, 2009.
15. S. López andC. F. Arias, "Simianrotavirus SA11 strains, " Journal of Virology, vol. 66, no. 3, p. 1832, 1992.
16. M. Ciarlet, J. E. Ludert, M. Iturriza-Gómara et al., "Initial interaction of rotavirus strainswithN-acetylneuraminic (sialic) acid residues on the cell surface correlates with VP4 genotype, not species of origin, " Journal of Virology, vol. 76, no. 8, pp. 4087-4095, 2002.
17. Y. Dong, C. Q.-Y. Zeng, J. M. Ball, M. K. Estes, and A. P. Morris, "The rotavirus enterotoxinNSP4mobilizes intracellular calcium in human intestinal cells by stimulating phospholipase C-mediated inositol 1, 4, 5-trisphosphate production, " Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 8, pp. 3960-3965, 1997.
18. F. Amblard, D. Delinsky, J. L. Arbiser, and R. F. Schinazi, "Facile purification of honokiol and its antiviral and cytotoxic properties, " Journal of Medicinal Chemistry, vol. 49, no. 11, pp. 3426-3427, 2006.
19. K.-H. Lan, Y.-W. Wang, W.-P. Lee et al., "Multiple effects of honokiol on the life cycle of hepatitis C virus, " Liver International, vol. 32, no. 6, pp. 989-997, 2012.
20. Y. Maruyama and H. Kuribara, "Overview of the pharmacological features of honokiol, " CNS Drug Reviews, vol. 6, no. 1, pp. 35-44, 2000.
21. M. K. Pyo, Y. K. Koo, and H. S. Yun-Choi, "Anti-platelet effect of the phenolic constituents isolated from the leaves of Magnolia obovata, " Natural Product Sciences, vol. 8, no. 4, pp. 147-151, 2002.
22. E.-A. Bae, M. J. Han, M. Lee, and D.-H. Kim, "In vitroinhibitory effect of some flavonoids on rotavirus infectivity, " Biological and Pharmaceutical Bulletin, vol. 23, no. 9, pp. 1122-1124, 2000.
23. H. J. Choi, J. H. Song, K. S. Park, and D. H. Kwon, "Inhibitory effects of quercetin 3-rhamnoside on influenza A virus replication, " European Journal of Pharmaceutical Sciences, vol. 37, no. 3-4, pp. 329-333, 2009.
24. Á. L. Álvarez, S. Melón, K. P. Dalton et al., "Apple pomace, a by-product from the Asturian cider industry, inhibits herpes simplex virus types 1 and 2 in vitro replication: study of its mechanisms of action, " Journal of Medicinal Food, vol. 15, no. 6, pp. 581-587, 2012.
25. A. E. Dos Santos, R. M. Kuster, K. A. Yamamoto et al., "Quercetin and quercetin 3-O-glycosides from Bauhinia longifolia (Bong.) Steud. show anti-Mayaro virus activity, " Parasites and Vectors, vol. 7, no. 1, article 130, 2014.
26. M. Debiaggi, F. Tateo, L. Pagani, M. Luini, and E. Romero, "Effects of propolis flavonoids on virus infectivity and replication, " Microbiologica, vol. 13, no. 3, pp. 207-213, 1990.
27. R. Vrijsen, L. Everaert, and A. Boeye, "Antiviral activity of flavones and potentiation by ascorbate, " Journal of General Virology, vol. 69, no. 7, pp. 1749-1751, 1988.
28. M. Materska, "Quercetin and its derivatives: chemical structure and bioactivity-a review, " Polish Journal of Food and Nutrition Sciences, vol. 58, no. 4, pp. 407-413, 2008.
29. D.-H. Kim, E.-A. Jung, I.-S. Sohng, J.-A. Han, T.-H. Kim, and M. J. Han, "Intestinal bacterial metabolism of flavonoids and its relation to some biological activities, " Archives of Pharmacal Research, vol. 21, no. 1, pp. 17-23, 1998.
30. D.-H. Kim, S.-Y. Kim, S.-Y. Park, and M. J. Han, "Metabolism of quercitrin by human intestinal bacteria and its relation to some biological activities, " Biological & Pharmaceutical Bulletin, vol. 22, no. 7, pp. 749-751, 1999.